Results 251 to 260 of about 14,299,063 (394)

Factor VIII Antibodies Demonstrate Type I or Type II Kinetics in Acquired Haemophilia A. [PDF]

Haemophilia
Kamel K, Sardo Infirri S, Riddell A, Chowdary P, Batty P.   +4 more
europepmc   +1 more source

An Insidious Case of Severe Acquired Factor VIII Inhibitor. [PDF]

Cureus, 2023
Patel F, Boldig K, Miatech J, Reddy P.
europepmc   +1 more source

Improved electroimmunoassay of factor VIII-related antigen. [PDF]

, 1977
A. L. Chute, J E Haddow, Robert F. Ritchie   +2 more
openalex   +1 more source

Pathway Analyses of Inherited Neuropathies Identify Putative Common Mechanisms of Axon Degeneration

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Inherited neuropathies (IN) are associated with over 100 different genetic mutations presenting with a variety of phenotypes. This complexity suggests multiple pathways may converge onto a limited number of downstream pathways to effect axonal injury.
Christopher R. Cashman, Craig Blackstone, Reza Sadjadi   +2 more
wiley   +1 more source

Pediatric Central Retinal Artery Occlusion in a Patient With Elevated Lipoprotein (A) and Factor VIII Levels. [PDF]

Cureus
Yi R, Gabbard RD, Saurey T, Al-Kadhi S, Hypes S, Fishburne B.   +5 more
europepmc   +1 more source

Multiple Molecular Forms of Factor VIII Antigen in Normal Individuals and Von Willebrand’s Disease Patients [PDF]

, 1977
T S Zimmerman, Janet R. Kimball, T S Edgington, C F Abildgaard   +3 more
openalex   +1 more source

EEG Response to Sedation Interruption Complements Behavioral Assessment After Severe Brain Injury

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Accurate assessment of the level of consciousness and potential to recover in patients with severe brain injury underpins crucial decisions in the intensive care unit but remains a major challenge for the clinical team. The neurological wake‐up test is a widely used assessment tool. However, many patients' behavioral responses during
Charlotte Maschke, Loretta Norton, Catherine Duclos, Miriam Han, Kira Dolhan, Geoffrey Laforge, Allison Frantz, Xiaoyu Wang, Hassan Al‐Hayawi, Tianyu Zhang, Raphaël Lavoie, Adrian M. Owen, Stefanie Blain‐Moraes   +12 more
wiley   +1 more source

Cell-Based Small-Molecule Screening Identifying Proteostasis Regulators Enhancing Factor VIII Missense Mutant Secretion. [PDF]

Biomolecules
Srivastava V, Liu Z, Wei W, Zhang Y, Paton JC, Paton AW, Mu T, Zhang B.   +7 more
europepmc   +1 more source

Letter: Commercial and NHS factor VIII concentrates. [PDF]

, 1976
J. D. Cash
openalex   +1 more source

Pregnancy Outcomes of Targeted Synthetic Disease‐Modifying Antirheumatic Drugs Among Patients With Autoimmune Diseases: A Scoping Review

Arthritis Care &Research, EarlyView.
Objective Targeted synthetic disease‐modifying antirheumatic drugs (tsDMARDs) have expanded the management of autoimmune diseases, including rheumatic diseases. As the use of these drugs grows, it is important to understand their effects on pregnancy.
Vienna Cheng, Neda Amiri, Vicki Cheng, Ursula Ellis, Jacquelyn J. Cragg, Mark Harrison, Laurie Proulx, Mary A. De Vera   +7 more
wiley   +1 more source